The effectiveness and safety of a Picosecond laser 1064-nm for treatment of lip hyperpigmentation in Thai population

Institute of Dermatology0 个研究点目标入组 41 人开始时间: 2023年10月5日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Lip hyperpigmentation characterized by bilateral hyperpigmented patch on upper and/or lower lip

•1. Lip hyperpigmentation from disease such as lichen planus, lupus erythematosus, pemphigus, pemphigoid, fixed drug eruptions, pigmented contact cheilitis, orofacial granulomatosis, ephelides, labial melanotic macule, acquired dermal melanocytosis, melanoacanthoma, lentigines, nevus, malignant melanoma, pigmented Bowen disease, squamous cell carcinoma, melanoma, actinic cheilitis, Lentiginosis syndromes, Addison disease, Cushing disease, Nelson syndrome, acromegaly, hyperthyroidism, and hemochromatosis which diagnose by history taking and physical examination
•2. History of procedures at lip such as tattoo, filler injection or laser
•3. History of keloid or hypertrophic scar
•4. History of labial herpes infection
•5. Infection at lip
•6. Pregnancy or breast feeding
•7. History of smoking
•8. History of drugs such as minocycline, zidovudine, cyclophosphamide, doxorubicin, escitalopram, levodopa, nicotine and tacrolimus

发起方

Institute of Dermatology